This chemical is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of biologically active compounds, particularly those targeting central nervous system disorders. Its structure, featuring a bromo and chlorobenzyloxy group, makes it suitable for developing potential therapeutic agents, such as serotonin receptor modulators or dopamine agonists. Researchers often employ it in the design and optimization of drug candidates, focusing on improving binding affinity and selectivity for specific receptors. Additionally, it may be used in the development of radiolabeled probes for imaging studies, aiding in the understanding of neurological pathways and disease mechanisms.